VivoSeq
Other

Other

2

Pipeline Programs↗

2

Active Trials↗

0

Companies Involved↗

Other is an early-stage landscape with 2 programs across 0 companies. 2 therapies are approved.

Intelligence

Pipeline Metrics

Competitive Density

21/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved2

Combined Oral Contraceptive (COC)

Penn State University

Contraceptive Vaginal Ring (CVR)

Penn State University

Analysis

Trial Status

3

clinical trials

Active, not recruiting1 · 33%
Recruiting1 · 33%
Completed1 · 33%

Clinical Trials

Trial Activity

The Effect of Oral vs. Non-oral Contraceptive Therapy on Bone Turnover Using 41Ca Methodology
Active, not recruiting·PPenn State University·Approved·NCT02367846·6 enrolled
Clinical Research in Hairy Cell Leukemia: Surveillance and Documentation of Clinical Outcomes in a Rare Form of Adult Leukemia
Recruiting·OOhio State University Comprehensive Cancer Center·N/A·NCT02560883·5,000 enrolled
Creating Welcoming Faith Communities for Believers With Serious Mental Illnesses: Testing an Environmental, Behavior-Oriented Intervention
Completed·TTemple University·Preclinical·NCT06336980·170 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)